Monday 19 October 2015

Office of Drugs Controller General ( India)  


Approval of the safety and efficacy of fixed dose combinations(FDCs) permitted for manufacture and sale in the country without the due approval from office of the DCG(I) for list of approved product, other then that list,  manufactures need to provide safety and efficacy reports


Sunday 18 October 2015

New Development in CRO Industry:


CDSCO news & updates on Clinical Research


CDSCO launches IT enabled system for online submission of applications & monitoring of Clinical trials

Sub-committee on online pharmacy may amend Rule 65 of D&C Rules.

Katoch committee recommends revival of PSUs for manufacturing critical drugs like penicillin, paracetamol, etc.

NPPA to bring cardiac stents under price control soon


Trust you will find this information useful for various business development initiatives and leverage this for effective cross selling of opportunities across the Lifesciences segment. This report can be shared with your existing/ target clients.

As always, we value your feedback.

Regards,